ClinicalTrials.Veeva

Menu

TetraSOD® Supplementation and Exercise Performance

L

Loughborough University

Status

Completed

Conditions

Placebo-Post
Tetraselmis Chuii-Post
Placebo-Pre
Tetraselmis Chuii-Pre

Treatments

Dietary Supplement: Tetraselmis chuii-Post
Other: Placebo-Pre
Other: Tetraselmis chuii-Pre
Dietary Supplement: Placebo-Post

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06831656
R19-P160

Details and patient eligibility

About

Tetraselmis chuii (TetraSOD) is a marine microalgae that has been reported to improve antioxidant responses in human skeletal muscle cells treated with TetraSOD and to improve recovery from muscle damaging exercise in humans supplemented with TetraSOD. However, the effects of TetraSOD supplementation on endurance performance and physiology is less clear. This study assessed the effect of short-term TetraSOD supplementation on endurance performance and physiology in healthy adults.

Full description

It is well documented that the production of reactive oxygen species (ROS; unstable molecules that react easily with and damage other molecules in a cell) increases in-line with the intensity and duration of exercise . Although increased ROS production during exercise is initially managed by a variety of 'antioxidants', continued ROS production exceeds the capacity of this antioxidant defense system leading to the development of oxidative stress and impaired exercise performance. Therefore, interventions that can lessen exercise-induced oxidative stress have the potential to improve exercise performance. While dietary supplementation with antioxidant vitamins (e.g. vitamin C and E) has this potential, such interventions do not typically improve exercise performance.

Therefore, further research is required to investigate the potential for novel nutritional supplements to lessen exercise-induced oxidative stress and to improve exercise performance.

Tetraselmis chuii (TetraSOD) is a natural marine microalgae product. Recent preliminary evidence suggests that treating human skeletal muscle cells with TetraSOD can increase the production of antioxidant enzymes to limit oxidative stress development. In addition, TetraSOD supplementation has been reported to improve recovery from muscle damaging exercise. However, the effects of TetraSOD supplementation on endurance performance and physiology is less clear.

The purpose of this study was to assess the effect of short-term TetraSOD supplementation on endurance performance and physiology in healthy adults.

Enrollment

15 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy male (as determined by the Health Screening Questionnaire)
  • Adult (aged ≥18 and ≤40 years old)
  • Recreationally-active (≥2 and ≤4 exercise sessions per week) and a V̇O2max of ≥ 35 mL/kg/min and ≤ 65 mL/kg/min as determined from the preliminary exercise test
  • No known history of gastric, digestive, cardiovascular, renal disease or any other orthopaedic diseases related to motor organs
  • Non-smoker
  • Healthy body mass index (BMI; ≥18.5 and ≤24.9 kg/m2)
  • Not using any dietary supplements, including antioxidant and nitrate-rich supplements, currently or in the past one month
  • Not a heavy drinker (≤ 14 units of alcohol) on most weeks
  • Not using medication that may affect study measures
  • Not participating in other studies currently or in the past two months prior to the consenting session (visit 1) or having an intention to participate in other studies over the period of this study

Exclusion criteria

  • Female
  • Aged <18 and >40 years old
  • Sedentary or highly trained with a respective V̇O2max of < 35 mL/kg/min and > 65 mL/kg/min as determined from the preliminary exercise test
  • History of gastric, digestive, cardiovascular, renal disease or any other orthopaedic diseases related to motor organs
  • Smoker
  • Unhealthy body mass index (BMI;<18.5 and >24.9 kg/m2)
  • Using any dietary supplements, including antioxidant and nitrate-rich supplements, currently or in the past one month
  • Heavy drinker (> 14 units of alcohol) on most weeks
  • Using medication that may affect study measures
  • Participating in other studies currently or in the past two months prior to the consenting session (visit 1) or having an intention to participate in other studies over the period of this study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

15 participants in 4 patient groups, including a placebo group

Placebo-Pre
Other group
Description:
No supplementation prior to undergoing the placebo supplement
Treatment:
Other: Placebo-Pre
Placebo-post
Placebo Comparator group
Description:
Placebo supplementation
Treatment:
Dietary Supplement: Placebo-Post
Tetraselmis chuii-Pre
Other group
Description:
No supplementation prior to undergoing the Tetraselmis chuii supplement
Treatment:
Other: Tetraselmis chuii-Pre
Tetraselmis chuii-Post
Active Comparator group
Description:
Tetraselmis chuii supplementation
Treatment:
Dietary Supplement: Tetraselmis chuii-Post

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems